17-74922980-C-T

Variant summary

Our verdict is Likely benign. The variant received -1 ACMG points: 0P and 1B. BS1_Supporting

The NM_173477.5(USH1G):​c.94G>A​(p.Gly32Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000554 in 1,407,906 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. G32G) has been classified as Likely benign.

Frequency

Genomes: not found (cov: 31)
Exomes 𝑓: 0.000055 ( 1 hom. )

Consequence

USH1G
NM_173477.5 missense

Scores

5
7
4

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: 7.90

Publications

0 publications found
Variant links:
Genes affected
USH1G (HGNC:16356): (USH1 protein network component sans) This gene encodes a protein that contains three ankyrin domains, a class I PDZ-binding motif and a sterile alpha motif. The encoded protein interacts with harmonin, which is associated with Usher syndrome type 1C. This protein plays a role in the development and maintenance of the auditory and visual systems and functions in the cohesion of hair bundles formed by inner ear sensory cells. Mutations in this gene are associated with Usher syndrome type 1G (USH1G). Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2013]
OTOP2 (HGNC:19657): (otopetrin 2) Predicted to enable proton channel activity. Predicted to be involved in proton transmembrane transport. Predicted to be located in plasma membrane. Predicted to be integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -1 ACMG points.

BS1
Variant frequency is greater than expected in population sas. GnomAdExome4 allele frequency = 0.0000554 (78/1407906) while in subpopulation SAS AF = 0.000948 (76/80176). AF 95% confidence interval is 0.000776. There are 1 homozygotes in GnomAdExome4. There are 59 alleles in the male GnomAdExome4 subpopulation. Median coverage is 31. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
USH1GNM_173477.5 linkc.94G>A p.Gly32Ser missense_variant Exon 1 of 3 ENST00000614341.5 NP_775748.2
USH1GNM_001282489.3 linkc.-163G>A 5_prime_UTR_variant Exon 1 of 3 NP_001269418.1 Q495M9B4DL95
USH1GXM_011524296.2 linkc.-550G>A upstream_gene_variant XP_011522598.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
USH1GENST00000614341.5 linkc.94G>A p.Gly32Ser missense_variant Exon 1 of 3 1 NM_173477.5 ENSP00000480279.1 Q495M9
OTOP2ENST00000580223.2 linkc.-285C>T 5_prime_UTR_variant Exon 1 of 5 1 ENSP00000463837.2 A0A6E1ZAN8
USH1GENST00000579243.1 linkn.94G>A non_coding_transcript_exon_variant Exon 1 of 3 2 ENSP00000462568.1 J3KSN5

Frequencies

GnomAD3 genomes
Cov.:
31
GnomAD2 exomes
AF:
0.000132
AC:
23
AN:
174768
AF XY:
0.000193
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000554
AC:
78
AN:
1407906
Hom.:
1
Cov.:
31
AF XY:
0.0000849
AC XY:
59
AN XY:
694822
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
32182
American (AMR)
AF:
0.00
AC:
0
AN:
37462
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25226
East Asian (EAS)
AF:
0.00
AC:
0
AN:
36710
South Asian (SAS)
AF:
0.000948
AC:
76
AN:
80176
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
49590
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5644
European-Non Finnish (NFE)
AF:
0.00000185
AC:
2
AN:
1082648
Other (OTH)
AF:
0.00
AC:
0
AN:
58268
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.522
Heterozygous variant carriers
0
5
10
15
20
25
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
31
Alfa
AF:
0.000122
Hom.:
0
ExAC
AF:
0.000127
AC:
15
Asia WGS
AF:
0.000577
AC:
2
AN:
3478

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Apr 20, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.94G>A (p.G32S) alteration is located in exon 1 (coding exon 1) of the USH1G gene. This alteration results from a G to A substitution at nucleotide position 94, causing the glycine (G) at amino acid position 32 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

not provided Uncertain:1
Oct 03, 2023
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces glycine with serine at codon 32 of the USH1G protein (p.Gly32Ser). The glycine residue is highly conserved and there is a small physicochemical difference between glycine and serine. This variant is present in population databases (rs752872097, gnomAD 0.1%). This variant has not been reported in the literature in individuals affected with USH1G-related conditions. ClinVar contains an entry for this variant (Variation ID: 1488686). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt USH1G protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.94
BayesDel_addAF
Uncertain
0.15
D
BayesDel_noAF
Pathogenic
0.39
CADD
Pathogenic
33
DANN
Benign
0.97
DEOGEN2
Uncertain
0.47
T
Eigen
Pathogenic
0.70
Eigen_PC
Uncertain
0.65
FATHMM_MKL
Uncertain
0.92
D
LIST_S2
Uncertain
0.96
D
M_CAP
Benign
0.079
D
MetaRNN
Uncertain
0.60
D
MetaSVM
Benign
-0.47
T
MutationAssessor
Uncertain
2.1
M
PhyloP100
7.9
PrimateAI
Pathogenic
0.84
D
Sift4G
Pathogenic
0.0
D
Polyphen
1.0
D
Vest4
0.85
MutPred
0.75
Gain of glycosylation at G32 (P = 0.0436);
MVP
0.52
ClinPred
0.40
T
GERP RS
4.1
PromoterAI
-0.027
Neutral
Varity_R
0.89
gMVP
0.82
Mutation Taster
=49/51
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs752872097; hg19: chr17-72919075; API